{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:11Z","timestamp":1777564391359,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011841.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000}}],"reference-count":345,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011841.pub3","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:05:21Z","timestamp":1750068321000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interventions for central serous chorioretinopathy: a network meta-analysis"],"prefix":"10.1002","volume":"2025","author":[{"given":"Clemens AK","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; St Franziskus Hospital; M\u00fcnster Germany"},{"name":"Eye Center, Medical Center, Medical Faculty, University of Freiburg; Freiburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riaz","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora CO USA"},{"name":"Department of Epidemiology; University of Colorado Anschutz Medical Campus; Aurora CO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurenz","family":"Pauleikhoff","sequence":"additional","affiliation":[{"name":"Eye Center, Medical Center, Medical Faculty; University of Freiburg; Freiburg Germany"},{"name":"Department of Ophthalmology, Academic Medical Center; University of Amsterdam; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"564-71","DOI":"10.3928\/23258160-20170630-07","article-title":"Early focal laser photocoagulation in acute central serous chorioretinopathy: a prospective, randomized study","volume":"48","author":"Ambiya","year":"2017","journal-title":"Ophthalmic Surgery, Lasers & Imaging Retina"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"535\u201340","DOI":"10.1016\/j.mjafi.2022.12.011","article-title":"532 nm versus 810 nm subthreshold micropulse laser in treatment of non-resolving central serous chorioretinopathy: a randomized controlled trial","volume":"80","author":"Ambiya","year":"2024","journal-title":"Medical Journal, Armed Forces India"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"Arora","year":"2019","journal-title":"Clinical & Experimental Optometry"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"Bae","year":"2011","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0006|cit6","unstructured":"Ranibizumab versus low-fluence photodynamic therapy in the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01325181"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.4103\/ijo.IJO_228_22","article-title":"Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy","volume":"70","author":"Beniwal","year":"2022","journal-title":"Indian Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0008|cit8","unstructured":"Boscia F Michele R Antonio L Nicola C Claudio F Salvatore F Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomized clinical trial of efficacy and safety Macula Society 2008 118"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0009|cit9","first-page":"ARVO E","article-title":"Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomised clinical trial of efficacy and safety","volume":"not reported","author":"Boscia","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"13","key":"10.1002\/14651858.CD011841.pub3-BIB0010|cit10","first-page":"1924","article-title":"Spironolactone reduces sub retinal fluid and choroidal thickness in CSR","volume":"55","author":"Behar-Cohen","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0012|cit12","unstructured":"Brancato R Bandello F Treatment of central serous chorioretinopathy with beta-blockers and calcium antagonists Macula Society 1994 114"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.oret.2023.10.024","article-title":"Comparing half-dose photodynamic therapy with subthreshold micropulse laser for the treatment of central serous chorioretinopathy","volume":"8","author":"Brelen","year":"2024","journal-title":"Ophthalmology Retina"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(14)73483-X","article-title":"Nadolol in the treatment of central serous retinopathy","volume":"116","author":"Browning","year":"1993","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0015|cit15","unstructured":"Chan PS Uy HS Salvosa F Silva PA Low dose transpupillary thermotherapy for the treatment of central serous chorioretinopathy American Academy of Ophthalmology 2006 290"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/FTD.0b013e31820beb02","article-title":"Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial","volume":"31","author":"Wu","year":"2011","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0018|cit18","first-page":"1-14","article-title":"Oral treatment of central serous chorioretinopathy patients using propranolol tablets","volume":"13","author":"Chen","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"325-33","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"Cheng","year":"2017","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0020|cit20","first-page":"56","article-title":"Combined half dose photodynamic therapy with verteporfin and intravitreal bevacizumab for chronic central serous chorioretinopathy","volume":"232","author":"Coskun","year":"2014","journal-title":"Ophthalmologica [Journal International d'Ophtalmologie; International Journal of Ophthalmology]"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/TCRM.S50407","article-title":"The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients","volume":"9","author":"Dang","year":"2013","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00417-022-05836-x","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3","volume":"261","author":"Feenstra","year":"2023","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"930-8","DOI":"10.1016\/j.oret.2022.04.014","article-title":"Crossover to half-dose photodynamic therapy or eplerenone in chronic central serous chorioretinopathy patients","volume":"6","author":"Feenstra","year":"2022","journal-title":"Ophthalmology Retina"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0024|cit24","first-page":"25","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment. SPECTRA trial report No. 4","volume":"101","author":"Feenstra","year":"2023","journal-title":"Acta Ophthalmologica"},{"issue":"524","key":"10.1002\/14651858.CD011841.pub3-BIB0025|cit25","first-page":"412","article-title":"The effect of laser diode micropulse laser in patients with acute central serous retinopathy in comparison with control group: a clinical trial study","volume":"37","author":"Ghanbari","year":"2019","journal-title":"Journal of Isfahan Medical School"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2341-6","DOI":"10.4103\/ijo.IJO_3401_20","article-title":"Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy","volume":"69","author":"Goel","year":"2021","journal-title":"Indian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"189-98","DOI":"10.1097\/IAE.0000000000002795","article-title":"Optical coherence tomography angiography-guided photodynamic therapy for acute central serous chorioretinopathy","volume":"41","author":"Hu","year":"2021","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0028|cit28","first-page":"103","article-title":"Effects of propranolol in patients with central serous chorioretinopathy","volume":"13","author":"Kianersi","year":"2008","journal-title":"Journal of Research in Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0029|cit29","first-page":"152","article-title":"Intravitreal ranibizumab for acute central serous chorioretinopathy","volume":"229","author":"Kim","year":"2013","journal-title":"Ophthalmologica [Journal International d'Ophtalmologie; International Journal of Ophthalmology]"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"205-12","DOI":"10.3341\/jkos.2015.56.2.205","article-title":"Comparison of choroidal hyperpermeability change after photodynamic therapy and ranibizumab for chronic central serous chorioretinopathy","volume":"56","author":"Kim","year":"2015","journal-title":"Journal of the Korean Ophthalmological Society"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2009.178327","article-title":"Selective retina therapy for acute central serous chorioretinopathy","volume":"95","author":"Klatt","year":"2011","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0032|cit32","unstructured":"Selective retina therapy in patients with idiopathic central serous retinopathy clinicaltrials.gov\/ct2\/show\/NCT00987077"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0033|cit33","first-page":"837-43","article-title":"Randomized clinical trial to compare micropulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy","volume":"46","author":"Kretz","year":"2015","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0034|cit34","first-page":"11-2","article-title":"Efficacy and safety of ranibizumab 0.5 mg in adult patients with visual impairment due to choroidal neovascularization associated with rare diseases: 12-month results of the Minerva study","volume":"236","author":"Hykin","year":"2016","journal-title":"Journal International d'Ophtalmologie [International Journal of Ophthalmology]"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA Study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"Pt 4","key":"10.1002\/14651858.CD011841.pub3-BIB0036|cit36","first-page":"473","article-title":"Long term results of treatment of central serous retinopathy - a preliminary report","volume":"105","author":"Ficker","year":"1986","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.63.10.674","article-title":"Argon laser photocoagulation in the treatment of central serous retinopathy","volume":"63","author":"Leaver","year":"1979","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0039|cit39","unstructured":"Clinical study to confirm the efficacy and safety of SRT (Selective Retina Therapy) in CSC (Central Serous Chorioretinopathy) trialsearch.who.int\/Trial2.aspx?TrialID=KCT0006325"},{"issue":"19","key":"10.1002\/14651858.CD011841.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3390\/jcm10194295","article-title":"The effect of selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy: a randomized, open-label, controlled clinical trial","volume":"10","author":"Lee","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00417-023-06147-5","article-title":"Optical coherence tomography angiography-guided vs indocyanine green angiography-guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results","volume":"261","author":"Li","year":"2023","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3341\/kjo.2010.24.3.155","article-title":"The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy","volume":"24","author":"Lim","year":"2010","journal-title":"Korean Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0043|cit43","unstructured":"Clinical efficacy and mechanistic evaluation of eplerenone for central serous chorioretinopathy - the VICI randomised trial trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN92746680"},{"issue":"10220","key":"10.1002\/14651858.CD011841.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"294-303","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Lotery","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41433-018-0212-2","article-title":"Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial","volume":"33","author":"Willcox","year":"2019","journal-title":"Eye (London, England)"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1687-90","DOI":"10.12669\/pjms.35.6.990","article-title":"Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy","volume":"35","author":"Loya","year":"2019","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1248-53","DOI":"10.1177\/1120672120915168","article-title":"A randomized clinical trial comparing prompt photodynamic therapy with 3 months observation in patients with acute central serous chorioretinopathy with central macular leakage","volume":"31","author":"Missotten","year":"2021","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0048|cit48","unstructured":"Eplerenone for the treatment of central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01990677"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"3559-63","DOI":"10.4103\/ijo.IJO_3499_20","article-title":"Effect of short-term meditation training in central serous chorioretinopathy","volume":"69","author":"Nongrem","year":"2021","journal-title":"Indian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3341\/kjo.2020.0112","article-title":"Evaluation of the safety and efficacy of selective retina therapy laser treatment in patients with central serous chorioretinopathy","volume":"35","author":"Oh","year":"2021","journal-title":"Korean Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0051|cit51","first-page":"ARVO E","article-title":"Topical brinzolamide for the treatment of idiopathic central serous chorioretinopathy","volume":"45","author":"Ontiveros-Orozco","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0052|cit52","first-page":"132","article-title":"Brinzolamide for topical treatment of idiopathic central serous chorioretinopathy","volume":"80","author":"Ontiveros-Orozco","year":"2006","journal-title":"Revista Mexicana de Oftalmolog\u00eda"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0053|cit53","unstructured":"The safe effective light dose of photodynamic therapy for chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01630863"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjophthalmol-2020-316837","article-title":"Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy","volume":"105","author":"Park","year":"2021","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","article-title":"Comparison of two mineral corticosteroid receptor antagonists for the treatment of central serous chorioretinopathy","volume":"37","author":"Pichi","year":"2017","journal-title":"International Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0056|cit56","unstructured":"The safety and efficacy of intravitreal aflibercept injection in patients with persistent central serous chorioretinopathy (CONTAIN) clinicaltrials.gov\/ct2\/show\/NCT01710332"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjophthalmol-2014-306018","article-title":"A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study","volume":"99","author":"Witkin","year":"2015","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0058|cit58","unstructured":"Effect of helicobacter pylori treatment on idiopathic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT00817245"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0059|cit59","first-page":"99","article-title":"The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Molecular Vision"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"962-9","DOI":"10.1097\/IAE.0000000000001649","article-title":"A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior)","volume":"38","author":"Rahimy","year":"2018","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0061|cit61","unstructured":"High-dose antioxidants for central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT00963131"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-12-20","article-title":"High-dose antioxidants for central serous chorioretinopathy: the randomized placebo-controlled study","volume":"12","author":"Ratanasukon","year":"2012","journal-title":"BMC Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0064|cit64","unstructured":"Micropulse diode laser treatment for chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01327170"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3928\/23258160-20130909-08","article-title":"Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial","volume":"44","author":"Roisman","year":"2013","journal-title":"Ophthalmic Surgery Lasers and Imaging"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0066|cit66","unstructured":"Pseudo-PDT in central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/nct02799992"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0067|cit67","first-page":"5357","article-title":"Comparison of visual and anatomical outcomes of half-dose photodynamic therapy and 689 nm laser treatment (pseudo-PDT) in eyes with chronic central serous chorioretinopathy","volume":"57 (12)","author":"Russo","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4103\/IJO.IJO_169_23","article-title":"Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy","volume":"71","author":"Sandeep","year":"2023","journal-title":"Indian Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0069|cit69","first-page":"NC01","article-title":"Efficacy and safety of oral eplerenone in acute central serous chorioretinopathy: a randomised controlled study","volume":"18","author":"Sarkar","year":"2024","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1167\/iovs.14-14470","article-title":"Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy","volume":"55","author":"Sawa","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1111\/aos.13491","article-title":"Eplerenone for chronic central serous chorioretinopathy - a randomized controlled prospective study","volume":"95","author":"Schwartz","year":"2017","journal-title":"Acta Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10384-012-0162-3","article-title":"Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"56","author":"Semeraro","year":"2012","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0073|cit73","first-page":"413","article-title":"Wavelength selection in management of central serous chorioretinopathy","volume":"35","author":"Shang","year":"1999","journal-title":"Chinese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0074|cit74","first-page":"638","article-title":"Clinical findings associated with propranolol and fenofibrate on acute central serous chorioretinopathy","volume":"10","author":"Shao","year":"2017","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0075|cit75","first-page":"167","article-title":"A multicenter randomized controlled study of antioxidant supplementation with lutein for the treatment of chronic central serous chorioretinopathy","volume":"56","author":"Kato","year":"2015","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0076|cit76","first-page":"159-66","article-title":"A multicenter randomized controlled study of antioxidant supplementation with lutein for chronic central serous chorioretinopathy","volume":"237","author":"Shinojima","year":"2017","journal-title":"Ophthalmologica [Journal International d'Ophtalmologie; International Journal of Ophthalmology]"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ophtha.2017.12.002","article-title":"Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS","volume":"125","author":"Staurenghi","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjophthalmol-2017-311096","article-title":"Spironolactone versus observation in the treatment of acute central serous chorioretinopathy","volume":"102","author":"Sun","year":"2018","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1592-9","DOI":"10.1038\/s41433-019-0692-8","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","volume":"34","author":"Sun","year":"2020","journal-title":"Eye (London, England)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0080|cit80","first-page":"31","article-title":"The PLACE trial: an open-label, multicenter, randomized controlled trial comparing half-dose photodynamic therapy with subthreshold micropulse laser for chronic central serous chorioretinopathy","volume":"96 (Supplement","author":"Boon","year":"2018","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0083|cit83","unstructured":"Photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2012-004555-36-FR"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0084|cit84","first-page":"19","article-title":"The safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"100 (Supplement","author":"Feenstra","year":"2022","journal-title":"Acta Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"721-9","DOI":"10.1097\/IAE.0000000000003363","article-title":"Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy","volume":"42","author":"Feenstra","year":"2022","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0086|cit86","unstructured":"A prospective randomized controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC) clinicaltrials.gov\/ct2\/show\/NCT01797861"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"Van Dijk","year":"2018","journal-title":"Ophthalmology"},{"issue":"Suppl 264","key":"10.1002\/14651858.CD011841.pub3-BIB0088|cit88","first-page":"40-41","article-title":"Pigment epithelial detachments in chronic central serous chorioretinopathy: effect of half-dose photodynamic therapy versus high-density subthreshold micropulse laser PLACE trial report No. 5","volume":"98","author":"Van Dijk","year":"2020","journal-title":"Acta Ophthalmologica"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0089|cit89","first-page":"1155","article-title":"Changes on multimodal imaging after treatment with photodynamic therapy or high-density subthreshold micropulse laser in chronic central serous chorioretinopathy","volume":"60","author":"Van Rijssen","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/IAE.0000000000003157","article-title":"Response of choroidal abnormalities to photodynamic therapy versus micropulse laser in chronic central serous chorioretinopathy: Place trial report No. 4","volume":"41","author":"Van Rijssen","year":"2021","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1-10","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE trial report No. 3","volume":"205","author":"Van Rijssen","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0092|cit92","first-page":"34-5","article-title":"Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser","volume":"99 (Suppl 266)","author":"Van Rijssen","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"80-9","DOI":"10.1016\/j.ajo.2020.04.007","article-title":"Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE Trial","volume":"216","author":"Van Rijssen","year":"2020","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0094|cit94","first-page":"35","article-title":"Crossover to half-dose photodynamic therapy or eplerenone treatment after failure of primary treatment in patients with chronic central serous chorioretinopathy: SPECTRA trial report no. 2","volume":"99 (Suppl 266)","author":"Boon","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0095|cit95","unstructured":"Photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2016-004119-11-NL"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00417-022-05836-x","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3","volume":"261","author":"Feenstra","year":"2022","journal-title":"Graefes Archives of Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0097|cit97","first-page":"35","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment. SPECTRA trial report no. 3","volume":"99 (Suppl 266)","author":"Feenstra","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0098|cit98","unstructured":"Photodynamic therapy versus eplerenone: treatment trial for chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/nct03079141"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0099|cit99","first-page":"18","article-title":"Twenty-four months follow-up of chronic central serous chorioretinopathy patients after treatment with oral eplerenone or half-dose photodynamic therapy, and crossover treatment: SPECTRA trial report No. 4","volume":"100","author":"Van Rijssen","year":"2022","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy","volume":"233","author":"Van Rijssen","year":"2022","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0101|cit101","first-page":"1-11","article-title":"Oral eplerenone versus observation in the management of acute central serous chorioretinopathy: a prospective, randomized comparative study","volume":"13","author":"Venkatesh","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-4-15","article-title":"Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial (ISRCTN84128484)","volume":"4","author":"Verma","year":"2004","journal-title":"BMC Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1737-42","DOI":"10.1007\/s00417-016-3315-0","article-title":"Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy","volume":"254","author":"Zavoloka","year":"2016","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0104|cit104","first-page":"1030","article-title":"Different doses of verteporfin photodynamic therapy for central exudative chorioretinopathy","volume":"30","author":"Zhang","year":"2012","journal-title":"Chinese Journal of Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","article-title":"A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial","volume":"133","author":"Zhao","year":"2015","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"682264","DOI":"10.3389\/fmed.2021.682264","article-title":"Subthreshold micropulse laser vs. conventional laser for central serous chorioretinopathy: a randomized controlled clinical trial","volume":"8","author":"Zhou","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"103908","DOI":"10.1016\/j.pdpdt.2023.103908","article-title":"A randomized non-inferiority trial of 577nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy","volume":"45","author":"Zhou","year":"2024","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0108|cit108","first-page":"1841","article-title":"Efficacy of compound Xueshuantong combined laser therapy on central serous chorioretinopathy","volume":"14","author":"Ainiwaer","year":"2014","journal-title":"International Eye Science"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00417-011-1884-5","article-title":"Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy","volume":"251","author":"Arevalo","year":"2013","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jop.2012.0072","article-title":"The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy","volume":"29","author":"Aydin","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"103807","DOI":"10.1016\/j.pdpdt.2023.103807","article-title":"Short term choroidal microvascular changes following photodynamic therapy in chronic central serous chorioretinopathy","volume":"44","author":"Bazvand","year":"2023","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00347-012-2688-7","article-title":"Treatment of central serous chorioretinopathy: micropulse photocoagulation versus bevacizumab","volume":"109","author":"Beger","year":"2012","journal-title":"Der Ophthalmologe"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3182670fa3","article-title":"Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy","volume":"33","author":"Behnia","year":"2013","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0114|cit114","first-page":"166","article-title":"Treatment of central serous chorioretinopathy with krypton yellow and green laser photocoagulation","volume":"9","author":"Bi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0115|cit115","unstructured":"Boscia F Caradscia N Furino C Dammacco R Sborgia G Reibaldi M Photodynamic therapy with low fluence PDT for chronic central serous chorioretinopathy: a short term pilot study Investigative Ophthalmology & Visual Science 2007 48 ARVO E Abstract 4151"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0116|cit116","first-page":"340","article-title":"Therapy of the so-called chorioretinitis centralis serosa with the laser-coagulator","volume":"160","author":"Bruha","year":"1972","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0117|cit117","first-page":"1284","article-title":"Comparison of two mineralocorticoid receptor antagonists in the treatment of central serous chorioretinopathy","volume":"56","author":"Carrai","year":"2015","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0118|cit118","first-page":"525","article-title":"Low dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"83","author":"Cervera","year":"2008","journal-title":"Archivos de la Sociedad Espanola de Oftalmologia"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"e0169152","DOI":"10.1371\/journal.pone.0169152","article-title":"Subfoveal choroidal thickness in central serous chorioretinopathy: a meta-analysis","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0120|cit120","unstructured":"Comparison of multiple treatments on central serous chorioretinopathy and their prognostic factors chictr.org.cn\/showprojEN.html?proj=123519&u_atoken=6fc2af1bd037be2938a97a537c7e6b2f&u_asig=1a0c384917369831863526905e0032"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0121|cit121","unstructured":"Observation on the clinical curative effect of acupuncture therapy with three points matching points combined with Western medicine nutritional support in the treatment of chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2100045677"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0122|cit122","unstructured":"The safe effective lowest power of subthreshold micropulse laser treatment in Chinese patients with acute or chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2300069591"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0123|cit123","unstructured":"Clinical observation of 577 nm micropulse laser combined with traditional Chinese medicine in the treatment of acute central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2300070688"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5507\/bp.2013.015","article-title":"Treatment of central serous chorioretinopathy with beta-blocker metipranolol","volume":"159","author":"Chrapek","year":"2015","journal-title":"Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, Czech Republic"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011841.pub3-BIB0125|cit125","first-page":"60","article-title":"The comparison of reduced-fluence photodynamic therapy with 577 nm yellow-wavelength pattern micropulse laser therapy in cases with chronic central serous chorioretinopathy: short term results","volume":"232","author":"Demirel","year":"2014","journal-title":"Ophthalmologica [Journal International d'Ophtalmologie; International Journal of Ophthalmology]"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0126|cit126","first-page":"336","article-title":"Changes in visual function before and after laser photocoagulation of central serous chorioretinopathy","volume":"13","author":"Di","year":"2013","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41433-020-01338-4","article-title":"Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"35","author":"Duan","year":"2021","journal-title":"Eye (London, England)"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ophtha.2014.06.038","article-title":"Visual cycle suppression via patching in central serous chorioretinopathy","volume":"121","author":"Earl","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0129|cit129","first-page":"740","article-title":"Argon laser treatment of central serous chorioretinopathy","volume":"13","author":"Fang","year":"2013","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0130|cit130","first-page":"434","article-title":"The potential utility of coumarin and horse chestnut extract for treatment of central serous chorioretinopathy","volume":"18","author":"Feily","year":"2009","journal-title":"Nigerian Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40942-022-00385-1","article-title":"Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analysis","volume":"8","author":"Felipe","year":"2022","journal-title":"International Journal of Retina and Vitreous"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00417-019-04486-w","article-title":"Corticosteroids usage and central serous chorioretinopathy: a meta-analysis","volume":"258","author":"Ge","year":"2020","journal-title":"Graefes Archive for Clinical & Experimental Ophthalmology"},{"issue":"2 (Special)","key":"10.1002\/14651858.CD011841.pub3-BIB0133|cit133","first-page":"595-9","article-title":"Efficacy and safety of iodized lecithin tablets versus spironolactone in alleviating central serous retinopathy among Chinese patients with uncontrolled diabetes","volume":"36","author":"Gu","year":"2023","journal-title":"Pakistan Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0134|cit134","first-page":"104","article-title":"Photodynamic therapy in patients with central serous chorioretinopathy","volume":"18","author":"Haas","year":"2004","journal-title":"Spektrum der Augenheilkunde"},{"issue":"5-6","key":"10.1002\/14651858.CD011841.pub3-BIB0135|cit135","first-page":"681","article-title":"Central serous retinopathy and alpha-blockaders","volume":"74","author":"Heinrich","year":"1974","journal-title":"Bulletin des Soci\u00e9t\u00e9s d'Ophtalmologie de France"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0136|cit136","first-page":"546","article-title":"Clinical effectiveness of lecithin-bound iodine on central serous chorioretinopathy following laser photocoagulation","volume":"24","author":"Huang","year":"2006","journal-title":"Chinese Ophthalmic Research"},{"issue":"41","key":"10.1002\/14651858.CD011841.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.2174\/1381612825666190123165914","article-title":"Pharmacotherapy of central serous chorioretinopathy: a review of the current treatments","volume":"24","author":"Iacono","year":"2018","journal-title":"Current Pharmaceutical Design"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0138|cit138","unstructured":"Effect of amiloride-h in central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20190311043009N1"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1097\/IAE.0000000000003615","article-title":"Multimodal imaging features and treatment responses of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"42","author":"Jeong","year":"2022","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11096-017-0460-4","article-title":"Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis","volume":"39","author":"Ji","year":"2017","journal-title":"International Journal of Clinical Pharmacy"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0141|cit141","unstructured":"Retinal laser photocoagulation to ameliorate choroidal congestion in central serous chorioretinopathy center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000047269"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0142|cit142","first-page":"1826","article-title":"Evaluation of the choroidal vascularity index after subthreshold yellow laser treatment in the patients with chronic central serous chorioretinopathy","volume":"36","author":"Kaderli","journal-title":"2022"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3928\/1542-8877-19970801-16","article-title":"Evaluation of visual function following argon laser photocoagulation in central serous retinopathy","volume":"28","author":"Khosla","year":"1997","journal-title":"Ophthalmic Surgery and Lasers"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0144|cit144","first-page":"S36","article-title":"Changes in retinal function using the multifocal electroretinogram after intravitreal anti-vascular endothelial growth factor injection in chronic central serous chorioretinopathy patients","volume":"146","author":"Kim","year":"2023","journal-title":"Documenta Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2012","journal-title":"Eye (London, England)"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0146|cit146","first-page":"841","article-title":"Effect of adenosine monophosphate on retinitis centralis","volume":"20","author":"Kurimoto","year":"1969","journal-title":"Nihon Ganka Kiyo"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/jop.2021.0120","article-title":"Photodynamic therapy with chlorin e6 derivative for chronic central serous chorioretinopathy (pilot study)","volume":"38","author":"Kustryn","year":"2022","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0148|cit148","first-page":"e293","article-title":"Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"89","author":"Lee","year":"2011","journal-title":"Acta Opthalmologica"},{"issue":"15","key":"10.1002\/14651858.CD011841.pub3-BIB0149|cit149","first-page":"2145","article-title":"Intravitreal bevacizumab injection for chronic central serous chorioretinopathy","volume":"123","author":"Li","year":"2010","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"102931","DOI":"10.1016\/j.pdpdt.2022.102931","article-title":"Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: a meta-analysis","volume":"39","author":"Li","year":"2022","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0151|cit151","first-page":"275-81","article-title":"Efficacy of optical coherence tomography angiography guided half-dose photodynamic therapy in the treatment of acute central serous chorioretinopathy","volume":"39","author":"Li","year":"2023","journal-title":"Chinese Journal of Ocular Fundus Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.2010.182121","article-title":"Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy","volume":"95","author":"Lim","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0153|cit153","first-page":"2451","article-title":"532 laser photocoagulation for the treatment of central serous chorioretinopathy","volume":"9","author":"Liu","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0155|cit155","first-page":"330","article-title":"Study in krypton laser combined with compound anisodine for central serous chorioretinopathy","volume":"11","author":"Long","year":"2011","journal-title":"International Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/eye.2015.208","article-title":"Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis","volume":"30","author":"Lu","year":"2016","journal-title":"Eye (London, England)"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0157|cit157","first-page":"214","article-title":"Conservative management of central serous retinopathy","volume":"97","author":"Lyons","year":"1977","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0158|cit158","first-page":"162","article-title":"Comparison of late results of conservative treatment and laser coagulation of central serous chorioretinopathy","volume":"89","author":"Mackowiakowa","year":"1987","journal-title":"Klinika Oczna"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0159|cit159","first-page":"603","article-title":"Successful treatment of central serous retinopathy by tranexamic acid injection","volume":"75","author":"Miyashita","year":"1971","journal-title":"Nihon Ganka Gakkai Zasshi"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/17469899.2017.1259565","article-title":"Mineralocorticoid receptor antagonists in the treatment of central serous chorioretinopathy","volume":"12","author":"Montorio","year":"2017","journal-title":"Expert Review of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0161|cit161","unstructured":"Pilot study of intravitreal bevacizumab vs. combination therapy for choroidal neovascularization secondary to causes other than age-related macular degeneration clinicaltrials.gov\/ct2\/show\/NCT01256580"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0162|cit162","unstructured":"Phase II, randomized, placebo-controlled study for the evaluation of finasteride in the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01585441"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0163|cit163","unstructured":"A prospective study of the use of micropulse 577 nm laser treatment in central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01982383"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0164|cit164","unstructured":"Results of suprachoroidal steroids injections in two chorioretinal diseases clinicaltrials.gov\/ct2\/show\/NCT05337332"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0165|cit165","unstructured":"Navigated microsecond laser for chronic central serous chorioretinopathy: MICROPULSE clinicaltrials.gov\/ct2\/show\/NCT05679180"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0166|cit166","first-page":"1-16","article-title":"Current pharmacological treatment options for central serous chorioretinopathy: a review","volume":"13","author":"Nicolo","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006982-198700730-00005","article-title":"Krypton and argon laser photocoagulation for central serous chorioretinopathy","volume":"7","author":"Novak","year":"1987","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3928\/23258160-20150101-04","article-title":"Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy","volume":"46","author":"Okamoto","year":"2015","journal-title":"Ophthalmic Surgery Lasers and Imaging Retina"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/15569527.2013.812104","article-title":"Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab","volume":"33","author":"Ozdemir","year":"2014","journal-title":"Cutaneous and Ocular Toxicology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0170|cit170","unstructured":"Intravitreal injection versus medical treatment for acute CSR trialsearch.who.int\/Trial2.aspx?TrialID=PACTR202204601902304"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0171|cit171","first-page":"1284","article-title":"Clinical study of method of activating blood and diuresis on central serous chorioretinopathy","volume":"10","author":"Peng","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0172|cit172","first-page":"1346","article-title":"Evaluation of risk factors associated with central serous chorioretinopathy and role of systemic propranolol as a treatment modality","volume":"16","author":"Praveen","year":"2024","journal-title":"International Journal of Pharmaceutical and Clinical Research"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0173|cit173","first-page":"299","article-title":"Enzymatic treatment of central serous retinopathy","volume":"28","author":"Radian","year":"1984","journal-title":"Revista de Chirurgie, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0174|cit174","first-page":"44","article-title":"Mifepristone as a treatment alternative to chronic serous chorioretinopathy","volume":"34","author":"Sanchez-Pacheco Tardon","year":"2010","journal-title":"Farmacia Hospitalaria"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"e8036","DOI":"10.5867\/medwave.2020.08.8035","article-title":"Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy","volume":"20","author":"Sanhueza","year":"2020","journal-title":"Medwave"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0176|cit176","first-page":"420","article-title":"Statistic studies of retinitis centralis","volume":"16","author":"Takagi","year":"1965","journal-title":"Nippon Ganka Kiyo"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0177|cit177","first-page":"251","article-title":"Argon laser photocoagulation in treatment of central serous retinopathy - a prospective randomized study","volume":"34","author":"Tewari","year":"1986","journal-title":"Indian Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1443\u201351","DOI":"10.1177\/11206721221145049","article-title":"Functionality of retinal vessels in central serous retinopathy: a comparison between eplerenone and photodynamic therapy","volume":"33","author":"Tombolini","year":"2023","journal-title":"European Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aos.15263","article-title":"Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses","volume":"101","author":"Van Dijk","year":"2022","journal-title":"Acta Opthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"Van Rijssen","year":"2019","journal-title":"Progress in Retinal and Eye Research"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0181|cit181","first-page":"384","article-title":"Clinical analysis of argon laser in treating central serous chorioretinopathy","volume":"9","author":"Wang","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0182|cit182","first-page":"1169","article-title":"Clinical observation of alliance application of compound anisodine and joletion in the treatment of central serous chorioretinopathy","volume":"9","author":"Wang","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.oret.2018.09.003","article-title":"Mineralocorticoid receptor antagonists in central serous chorioretinopathy: a meta-analysis of randomized controlled trials","volume":"3","author":"Wang","year":"2019","journal-title":"Ophthalmology Retina"},{"issue":"0","key":"10.1002\/14651858.CD011841.pub3-BIB0184|cit184","first-page":"242","article-title":"Ruby laser photocoagulation therapy of central serous retinopathy. A preliminary report","volume":"12","author":"Watzke","year":"1974","journal-title":"Modern Problems in Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9394(79)90571-3","article-title":"Direct and indirect laser photocoagulation of central serous choroidopathy","volume":"88","author":"Watzke","year":"1979","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001386","article-title":"Nondamaging retinal laser therapy for treatment of central serous chorioretinopathy: what is the evidence?","volume":"37","author":"Wood","year":"2017","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0187|cit187","first-page":"2295","article-title":"Clinical observation of jolethin combined with argon laser for central serous chorioretinopathy","volume":"10","author":"Wu","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"17","key":"10.1002\/14651858.CD011841.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"e25722","DOI":"10.1097\/MD.0000000000025722","article-title":"Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: a meta-analysis","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/OPX.0000000000001394","article-title":"Combined topical anti-inflammatory and oral acetazolamide in the treatment of central serous chorioretinopathy","volume":"96","author":"Wuarin","year":"2019","journal-title":"Optometry and Vision Science"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0190|cit190","first-page":"1688","article-title":"Efficacy comparison of 577 nm micropulse laser and drug in the treatment of central serous chorioretinopathy","volume":"13","author":"Xu","year":"2013","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0191|cit191","first-page":"701","article-title":"Treatment of juxtafoveal central serous chorioretinopathy by compound anisodine injection","volume":"14","author":"Xu","year":"2014","journal-title":"International Eye Science"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0192|cit192","first-page":"1160","article-title":"Compound Xueshuantong capsule joint laser treating central serous chorioretinopathy","volume":"13","author":"Ye","year":"2013","journal-title":"International Eye Science"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12886-022-02331-z","article-title":"Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy","volume":"22","author":"Zeng","year":"2022","journal-title":"BMC Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0194|cit194","first-page":"872","article-title":"Clinical observation of laser treatment for central serous chorioretinopathy choroidal diseases and study on relationship between visual acuity with leakage location","volume":"14","author":"Zhang","year":"2014","journal-title":"International Eye Science"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s10792-020-01479-1","article-title":"Efficacy of mineralocorticoid receptor antagonist for central serous chorioretinopathy: a meta-analysis","volume":"40","author":"Zhang","year":"2020","journal-title":"International Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0196|cit196","first-page":"2124","article-title":"Hyperbaric oxygen therapy combined with jolethin in treating central serous chorioretinopathy","volume":"13","author":"Zheng","year":"2013","journal-title":"International Eye Science"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0197|cit197","first-page":"2037","article-title":"Intravitreal bevacizumab plus brinzolamide versus intravitreal bevacizumab for treatment of central serous chorioretinopathy: pilot study","volume":"57","author":"Alvarez-Felix","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0198|cit198","unstructured":"Subthreshold micropulse yellow (577 nm) laser versus half-dose photodynamic therapy for central serous chorioretinopathy: a randomized controlled pilot study trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12617000096358"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0199|cit199","unstructured":"Prospective randomized controlled study of OCT guided 577 nm micropulse laser noninvasive treatment of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2000036226"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0200|cit200","unstructured":"Efficacy and safty of subthreshold micropulse laser photocoagulation for central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2000036539"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0201|cit201","unstructured":"The efficacy and safety of exogenous melatonin in the treatment of acute central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2300073143"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0202|cit202","unstructured":"Clinical treatment and analysis of risk factors of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-IPR-16008428"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0203|cit203","unstructured":"Eplerenone for acute central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/08\/027408"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0204|cit204","unstructured":"To compare the efficacy of lasers of two different wavelengths (810 nm and 577 nm) for the treatment of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/10\/028374"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0205|cit205","unstructured":"A randomized double blinded sham-controlled study to determine the efficacy and safety of dexamethasone implants in chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2023\/06\/053775"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0206|cit206","unstructured":"Intravitreal brolucizumab in management of chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2023\/06\/053778"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0207|cit207","unstructured":"Early treatment of patients with central serous retinopathy: a randomized controlled trial - CSR & PDT apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2009-017959-98-NL"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0208|cit208","unstructured":"Prednisolone eye drop in chronic central serous chorioretinopathy: a randomised clinical trial trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2022-000338-41-NL"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0209|cit209","unstructured":"Pred Forte\u00ae in chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=NL-OMON51739"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0210|cit210","unstructured":"Efficacy and safety of crocin supplementation in patients with central serous chorioretinopathy (CSCR) trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20110811007297N7"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0211|cit211","unstructured":"Evaluation of intravitreal injection of bevacizumab for treatment of chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=IRCT201202198983N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0212|cit212","unstructured":"Evaluation of treatment options of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=IRCT2017041533448N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0213|cit213","unstructured":"Effect of spironolactone on treatment of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=IRCT2017101536801N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0214|cit214","unstructured":"The effect of Diode micropulse laser on acute central serous chorioretinopathy in comparing to control group in patients of Isfahan Feiz hospital in 2016-2017 trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20171030037087N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0215|cit215","unstructured":"The efficacy of eplerenon drug in patient with acute CSCR (Central Serous Chorioretinopathy) trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20180825040860N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0216|cit216","unstructured":"Assessment of eplerenone effects on the imaging findings in acute central serous chorioretinopathy: a randomized clinical trial trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20191116045458N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0217|cit217","unstructured":"Evaluation of the effect of eplerenone in central serous chorioretinopathy (CSCR) trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20220122053792N1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0218|cit218","unstructured":"Study on the effects of supplements containing lutein on spontaneous resolution in eyes with chronic central serous chorioretinopathy apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000005372"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0219|cit219","unstructured":"Clinical study to confirm the efficacy and safety of SRT (Selective Retina Therapy) in CSC (Central Serous Chorioretinopathy) trialsearch.who.int\/Trial2.aspx?TrialID=KCT0006325"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0220|cit220","unstructured":"Central serous chorioretinopathy treated by modified photodynamic therapy clinicaltrials.gov\/ct2\/show\/NCT01019668"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0221|cit221","unstructured":"Effect of spironolactone in treating chronic non-resolutive central serous chorioretinitis clinicaltrials.gov\/ct2\/show\/NCT01552044"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0222|cit222","unstructured":"Efficacy and safety of intravitreal aflibercept injection for subacute central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01971190"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0223|cit223","unstructured":"Eplerenone for the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02153125"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0224|cit224","unstructured":"A randomized, double-masked, placebo controlled study of the beneficial effects of eplerenone on central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02215330"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0225|cit225","unstructured":"Short-term oral mifepristone for central serous chorioretinopathy. A placebo-controlled dose ranging study of mifepristone in the treatment of CSC (STOMP-CSC) clinicaltrials.gov\/ct2\/show\/NCT02354170"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0226|cit226","unstructured":"Short-term oral mifepristone for central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/nct02587767"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0227|cit227","unstructured":"Micropulse 577 nm laser vs traditional laser treatment in central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02735213"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0228|cit228","unstructured":"Treatment trial for acute central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02784665"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0229|cit229","unstructured":"Panmacular versus minimal micropulse laser therapy in central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT04410861"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0230|cit230","unstructured":"Efficacy and safety of crocin supplementation in patients with central serous chorioretinopathy (CSCR) clinicaltrials.gov\/ct2\/show\/NCT04936490"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0231|cit231","unstructured":"Different doses of vPDT in the treatment of cCSC clinicaltrials.gov\/ct2\/show\/NCT05390619"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0232|cit232","unstructured":"Subthreshold nanosecond laser for non-resolving central serous chorioretinopathy (NANO-C) clinicaltrials.gov\/ct2\/show\/NCT05570591"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0233|cit233","unstructured":"Steroid eye drops in chronic central serous chorioretinopathy (PICS) clinicaltrials.gov\/ct2\/show\/NCT05633576"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0234|cit234","unstructured":"Two patterns of micropulse laser in the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT05687422"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0235|cit235","unstructured":"A prospective randomised controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC) trialsearch.who.int\/Trial2.aspx?TrialID=NL-OMON39842"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0236|cit236","unstructured":"Long-term follow-up and cross-over of treatment with high-density micropulse laser and half-dose photodynamic therapy in participants of the PLACE trial for chronic central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=NL-OMON40728"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0237|cit237","unstructured":"Comparative study of argon laser and aspirin in treatment of central serous chorioretinopathy trialsearch.who.int\/Trial2.aspx?TrialID=PACTR201706002163811"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.eye.6701905","article-title":"Central serous chorioretinopathy associated with testosterone therapy","volume":"20","author":"Ahad","year":"2006","journal-title":"Eye (London, England)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0239|cit239","first-page":"1513","article-title":"Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy","volume":"11:10","author":"Ambiya","year":"2016","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2005.01027.x","article-title":"Long-term macular function in eyes with central serous chorioretinopathy","volume":"33","author":"Baran","year":"2005","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"2672\u20139","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaophthalmol.2015.1320","article-title":"Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography","volume":"133","author":"Bonini Filho","year":"2015","journal-title":"JAMA Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"1229\u201333","DOI":"10.1001\/archopht.1993.01090090081024","article-title":"Central serous chorioretinopathy in endogenous hypercortisolism","volume":"111","author":"Bouzas","year":"1993","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"107747","DOI":"10.1016\/j.exer.2019.107747","article-title":"Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents","volume":"187","author":"Canonica","year":"2019","journal-title":"Experimental Eye Research"},{"issue":"17","key":"10.1002\/14651858.CD011841.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.3390\/ijms22179618","article-title":"Pathogenic effects of mineralocorticoid pathway activation in retinal pigment epithelium","volume":"22","author":"Canonica","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"23","author":"Cardillo Piccolino","year":"2003","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0250|cit250","volume-title":"Dictionary of Eye Terminology","author":"Cassin","year":"2006"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00169099","article-title":"Long-term follow-up of central serous retinopathy in 150 patients","volume":"81","author":"Castro-Correia","year":"1992","journal-title":"Documenta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0253|cit253","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses. In Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (last updated October 2019). Cochrane 2024 Available from training.cochrane.org\/handbook\/archive\/v6.5"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(03)00462-8","article-title":"Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin","volume":"136","author":"Chan","year":"2003","journal-title":"American Journal of Opthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","article-title":"Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study","volume":"42","author":"Chatziralli","year":"2017","journal-title":"Current Eye Research"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"2749296","DOI":"10.1155\/2019\/2749296","article-title":"Association between central serous chorioretinopathy and risk of depression: a population-based cohort study","volume":"2019","author":"Chen","year":"2019","journal-title":"Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmology Retina"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12916-021-02166-3","article-title":"ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis","volume":"19","author":"Chiocchia","year":"2021","journal-title":"BMC Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1507\/endocrj.47.401","article-title":"Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease","volume":"47","author":"Chou","year":"2000","journal-title":"Endocrine Journal"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/eye.2013.236","article-title":"Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review","volume":"27","author":"Chung","year":"2013","journal-title":"Eye (London, England)"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.mp.4002041","article-title":"Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57\/Bl6 mice","volume":"13","author":"Clark","year":"2008","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/112067210601600213","article-title":"Central serous chorioretinopathy and Helicobacter pylori","volume":"16","author":"Cotticelli","year":"2006","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0264|cit264","unstructured":"Covidence Veritas Health Innovation 2024"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0265|cit265","first-page":"1190","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"JAMA Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3928\/23258160-20160126-05","article-title":"Vascularization of irregular retinal pigment epithelial detachments in chronic central serous chorioretinopathy evaluated with OCT angiography","volume":"47","author":"De Carlo","year":"2016","journal-title":"Ophthalmic Surgery, Lasers & Imaging Retina"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0269|cit269","unstructured":"U.S. Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: an evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Progress in Retinal and Eye Research"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/jcm12062088","article-title":"Intervortex venous anastomosis in the macula in central serous chorioretinopathy imaged by en face optical coherence tomography","volume":"12","author":"Fern\u00e1ndez-Vigo","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":"Finasteride for chronic central serous chorioretinopathy","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mehy.2004.02.020","article-title":"Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis","volume":"63","author":"Giusti","year":"2004","journal-title":"Medical Hypotheses"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0274|cit274","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjo.2006.098277","article-title":"The potential role of testosterone in central serous chorioretinopathy","volume":"91","author":"Grieshaber","year":"2007","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"issue":"7414","key":"10.1002\/14651858.CD011841.pub3-BIB0279|cit279","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0280|cit280","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0282|cit282","unstructured":"Higgins JP Eldrige S Chapter 23: Including variants on randomized trials. In Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated Aug 2023). Cochrane 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0283|cit283","volume-title":"Visual Science and Related Clinical Terms","author":"Hofstetter","year":"2000"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1038\/s41598-022-13208-y","article-title":"Early anatomical changes and association with photodynamic therapy induced acute exudative maculopathy in patients with macular diseases","volume":"12","author":"Honda","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0285|cit285","first-page":"1145\u201354","article-title":"The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysis","volume":"20","author":"Huon","year":"2016","journal-title":"Schlaf & Atmung [Sleep & Breathing]"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(98)00378-X","article-title":"Plasminogen activator inhibitor 1 in central serous chorioretinopathy","volume":"127","author":"Iijima","year":"1999","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0161-6420(02)01303-9","article-title":"Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"e2524","DOI":"10.1097\/MD.0000000000002524","article-title":"Selective retina therapy in patients with chronic central serous chorioretinopathy: a pilot study","volume":"95","author":"Kang","year":"2016","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0289|cit289","first-page":"103","article-title":"Effects of propranolol in patients with central serous chorioretinopathy","volume":"13","author":"Kianersi","year":"2008","journal-title":"Journal of Research in Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3928\/15428877-20090430-14","article-title":"Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy","volume":"40","author":"Kim","year":"2009","journal-title":"Ophthalmic Surgery, Lasers and Imaging Retina"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with nontreatment of central serous choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e31825dd281","article-title":"Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis","volume":"32","author":"Kurup","year":"2012","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2006.090282","article-title":"Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study","volume":"90","author":"Lai","year":"2006","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1464\u201377","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause","volume":"38","author":"Lai","year":"2018","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0296|cit296","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000535930","article-title":"Clinical landscape of central serous chorioretinopathy in Germany: retina.net CSC registry report number 1","volume":"247","author":"Lange","year":"2024","journal-title":"Ophthalmologica [Journal International d'Ophtalmologie; International Journal of Ophthalmology]"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0297|cit297","first-page":"178","article-title":"Differential diagnoses of central serous chorioretinopathy: is that really a central serous chorioretinopathy?","volume":"122","author":"Lange","year":"2025","journal-title":"Die Ophthalmologie"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1111\/aos.12482","article-title":"System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy","volume":"92","author":"Ma","year":"2014","journal-title":"Acta Ophthalmologica"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jfo.2014.05.007","article-title":"Central serous chorioretinopathy: clinical-anatomic correlations","volume":"37","author":"Maalej","year":"2014","journal-title":"Journal Fran\u00e7ais d'Ophtalmologie"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":"Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0303|cit303","first-page":"291","article-title":"Xenon light-exposure as a treatment of central serous retinopathy (a preliminary report)","volume":"20","author":"Mitsui","year":"1969","journal-title":"Nippon Ganka Kiyo"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/bjo.2004.049403","article-title":"Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy","volume":"89","author":"Montero","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/IAE.0b013e318156db8a","article-title":"The natural history of pigment epithelial detachment associated with central serous chorioretinopathy","volume":"27","author":"Mudvari","year":"2007","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0309|cit309","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choriodal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Prunte","year":"1996","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0310|cit310","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","article-title":"Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial","volume":"149","author":"Reibaldi","year":"2010","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0313|cit313","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/112067210401400115","article-title":"Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy","volume":"14","author":"Ricci","year":"2004","journal-title":"European Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schl\u00f6tzer-Schrehardt","year":"2002","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0316|cit316","first-page":"830","article-title":"Photodynamic effects on choroidal neovascularization and physiological choroid","volume":"43","author":"Schmidt-Erfurth","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0317|cit317","unstructured":"Shuler RK Mruthyunjaya P Diagnosing and managing central serous chorioretinopathy www.aao.org\/publications\/eyenet\/200602\/pearls.cfm [EyeNet Magazine, February 2006]"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub3-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","article-title":"Micropulsed diode laser therapy: evolution and clinical applications","volume":"55","author":"Sivaprasad","year":"2010","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"2070\u20139","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0320|cit320","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0321|cit321","unstructured":"Systematic Review Data Repository (SRDR) srdr.ahrq.gov\/"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.preteyeres.2021.100955","article-title":"Serous business: delineating the broad spectrum of diseases with subretinal fluid in the macula","volume":"84","author":"Van Dijk","year":"2021","journal-title":"Progress in Retinal and Eye Research"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aos.15263","article-title":"Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses","volume":"101","author":"Van Dijk","year":"2023","journal-title":"Acta Ophthalmologica"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub3-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2018.00039","article-title":"Cushing's syndrome and hypothalamic-pituitary-adrenal axis hyperactivity in chronic central serous chorioretinopathy","volume":"20","author":"Van Halen","year":"2018","journal-title":"Frontiers in Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1111\/aos.13952","article-title":"Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy","volume":"97","author":"Van Haalen","year":"2019","journal-title":"Acta Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/aos.14269","article-title":"Hair cortisol concentrations in chronic central serous chorioretinopathy","volume":"98","author":"Van Haalen","year":"2020","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0327|cit327","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"Van Rijssen","year":"2019","journal-title":"Progress in Retinal and Eye Research"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Opthalmologica"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0900900103","article-title":"Multivariate random-effects meta-analysis","volume":"9","author":"White","year":"2009","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.1995.13.1.157","article-title":"Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production","volume":"13","author":"Winquist","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1038\/s41598-019-45080-8","article-title":"Optical coherence tomography angiography for diagnosis of choroidal neovascularization in chronic central serous chorioretinopathy after photodynamic therapy","volume":"9","author":"Wu","year":"2019","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub3-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0336|cit336","volume-title":"Ophthalmology","author":"Yanoff","year":"2013"},{"key":"10.1002\/14651858.CD011841.pub3-BIB0337|cit337","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub3-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.survophthal.2023.03.001","article-title":"Comparing interventions for chronic central serous chorioretinopathy: a network meta-analysis","volume":"68","author":"You","year":"2023","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.1111\/jpi.12802","article-title":"Melatonin prevents experimental central serous chorioretinopathy in rats","volume":"73","author":"Yu","year":"2022","journal-title":"Journal of Pineal Research"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub3-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0341|cit341","first-page":"1784","article-title":"Risk factors for incident central serous retinopathy: case-control analysis of a US national managed care population","volume":"103","author":"Zhou","year":"2019","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub3-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms23031278","article-title":"Chronic systemic dexamethasone regulates the mineralocorticoid\/glucocorticoid pathways balance in rat ocular tissues","volume":"23","author":"Zola","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub3-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"14111","DOI":"10.1038\/s41598-023-41126-0","article-title":"Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)","volume":"13","author":"Zola","year":"2023","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub3-BIB0344|cit344","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","author":"Salehi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub3-BIB0345|cit345","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011841.pub2","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","author":"Salehi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:20:21Z","timestamp":1774538421000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011841.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":345,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011841.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]}}}